Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
54,142,705
-
Shares change
-
+977,140
-
Total reported value, excl. options
-
$2,443,759,313
-
Value change
-
+$49,081,267
-
Put/Call ratio
-
383%
-
Number of buys
-
116
-
Number of sells
-
90
-
Price
-
$45.05
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q1 2025
As of 31 Mar 2025 Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) had 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,142,705 shares of stock of the company.
Largest 10 holders included Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc., BVF INC/IL, VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, Novo Holdings A/S, STATE STREET CORP, CITADEL ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 213 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.